Literature DB >> 10770774

Glycopeptide-resistant Enterococcus faecium BM4416 is a VanD-type strain with an impaired D-Alanine:D-Alanine ligase.

B Perichon1, B Casadewall, P Reynolds, P Courvalin.   

Abstract

VanD-type Enterococcus faecium BM4416 was constitutively resistant to vancomycin and to teicoplanin by synthesis of peptidoglycan precursors ending in D-alanyl-D-lactate. Like E. faecium BM4339, the only VanD-type strain described so far, BM4416 produced an impaired D-alanine:D-alanine ligase. Unlike for BM4339, which had a 5-bp insertion in ddl, inactivation of the gene in BM4416 was due to insertion of IS19.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770774      PMCID: PMC89867          DOI: 10.1128/AAC.44.5.1346-1348.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens.

Authors:  D A Relman; J S Loutit; T M Schmidt; S Falkow; L S Tompkins
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

2.  VanD-type glycopeptide-resistant Enterococcus faecium BM4339.

Authors:  B Perichon; P Reynolds; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci.

Authors:  M Arthur; F Depardieu; L Cabanié; P Reynolds; P Courvalin
Journal:  Mol Microbiol       Date:  1998-11       Impact factor: 3.501

4.  Overexpression, purification, and characterization of VanX, a D-, D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147.

Authors:  Z Wu; G D Wright; C T Walsh
Journal:  Biochemistry       Date:  1995-02-28       Impact factor: 3.162

5.  Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

Authors:  T D Bugg; G D Wright; S Dutka-Malen; M Arthur; P Courvalin; C T Walsh
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

6.  Identification of the uncultured bacillus of Whipple's disease.

Authors:  D A Relman; T M Schmidt; R P MacDermott; S Falkow
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

7.  Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria.

Authors:  S L Liu; A Hessel; K E Sanderson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.

Authors:  P E Reynolds; F Depardieu; S Dutka-Malen; M Arthur; P Courvalin
Journal:  Mol Microbiol       Date:  1994-09       Impact factor: 3.501

9.  Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.

Authors:  M Arthur; C Molinas; F Depardieu; P Courvalin
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

10.  PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid.

Authors:  K Greisen; M Loeffelholz; A Purohit; D Leong
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

View more
  13 in total

1.  Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil.

Authors:  L M Dalla Costa; P E Reynolds; H A Souza; D C Souza; M F Palepou; N Woodford
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.

Authors:  Florence Depardieu; Mathias Kolbert; Hendrik Pruul; Jan Bell; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 3.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  First infection with VanD-type glycopeptide-resistant Enterococcus faecium in Europe.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Nicole Bouziges; Albert Sotto
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR.

Authors:  Florence Depardieu; Bruno Perichon; Patrice Courvalin
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea.

Authors:  Ji Young Huh; Wee Gyo Lee; Kyungwon Lee; Wan Shik Shin; Jin Hong Yoo
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

7.  Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium.

Authors:  Agnès Lefort; Louis Garry; Florence Depardieu; Patrice Courvalin; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

8.  Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) gene.

Authors:  David A Boyd; Mark A Miller; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 9.  VanD-type vancomycin-resistant Enterococcus faecium 10/96A.

Authors:  Florence Depardieu; Peter E Reynolds; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  vanD and vanG-like gene clusters in a Ruminococcus species isolated from human bowel flora.

Authors:  M-C Domingo; A Huletsky; R Giroux; F J Picard; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.